No.	Recommendations/Statements	GRADE	Sources
16.5.	Biomarkers (5-type HPV mRNA, HPV type-specific persistence) must not be used to follow up patients treated for CIN 2/3 lesions.	⊕⊖⊖⊖ A	134 ,  137 ,  151 ,  153 ,  154 ,  155 ,  156 ,  157